Regeneron Pharmaceuticals | Nettoindtægt

Net Income Lave om Dato
AbbVie USD 822M 956M 2023-12
Agios Pharmaceuticals USD -95940000 4.62M 2023-12
Alnylam Pharmaceuticals USD -137870000 285.62M 2023-12
Amgen USD 767M 963M 2023-12
AstraZeneca USD 1.37B 444M 2023-09
Eli Lilly USD 2.19B 2.25B 2023-12
Gilead Sciences USD 1.43B 751M 2023-12
GlaxoSmithKline GBP 1.46B 160M 2023-09
Incyte USD 201.08M 29.81M 2023-12
Ionis Pharmaceuticals USD -9263000 138.15M 2023-12
Kyowa Hakko Kirin JPY 31.91B 23.02B 2023-09
Moderna USD 217M 3.85B 2023-12
Neurocrine Biosciences USD 83.1M 12.4M 2023-09
Opthea USD -65422070 11.68M 2023-06
Pfizer USD -3368000000 986M 2023-12
Regeneron Pharmaceuticals USD 1.16B 151.8M 2023-12
Roche Holding CHF 7.14B 3.25B 2023-06
Sarepta Therapeutics USD -40937000 17M 2023-09
Teva Pharmaceutical Industries USD 79M 941M 2023-09
Ultragenyx Pharmaceutical USD -123190000 36.46M 2023-12
United Therapeutics USD 217.1M 50.5M 2023-12
Vertex Pharmaceuticals USD 1.04B 119.6M 2023-09



Regeneron Pharmaceuticals Nettoindtægt - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2024.